Details for New Drug Application (NDA): 018125
✉ Email this page to a colleague
NDA 018125 describes HALOG, which is a drug marketed by Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb, and is included in six NDAs. It is available from two suppliers. Additional details are available on the HALOG profile page.
The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
Summary for 018125
| Tradename: | HALOG |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | halcinonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018125
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.025% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
